Deer Park

Mexico’s Energy Reform Benefits Motorists but Counterreform Frustrates Investors, says Mexico Energy Intelligence

Retrieved on: 
Tuesday, July 18, 2023

In a trilogy of reports by Mexico Energy Intelligence™, an industry newsletter, the recent past and outlook for energy reform are seen as blessings and concerns.

Key Points: 
  • In a trilogy of reports by Mexico Energy Intelligence™, an industry newsletter, the recent past and outlook for energy reform are seen as blessings and concerns.
  • According to one report , Uber drivers in Mexico City are grateful for the Energy Reform of 2013-14 that allows gasoline brands other than Pemex into the market, bringing better value and cleaner restrooms.
  • The reform also featured international public auctions of oil leases and long-term contracts in the wholesale electricity market.
  • “Their sale would make people rethink the idea that energy security requires state ownership.”
    George Baker is the managing principal of Baker & Associates, Energy Consultants, and publisher since 1996 of Mexico Energy Intelligence™.

RH Announces the Unveiling of RH England, the Gallery at the Historic Aynho Park

Retrieved on: 
Friday, June 9, 2023

RH (NYSE: RH) announced today the opening of RH England, The Gallery at the Historic Aynho Park – a 400-year-old landmark estate representing the most inspiring and immersive physical expression of the brand to date.

Key Points: 
  • RH (NYSE: RH) announced today the opening of RH England, The Gallery at the Historic Aynho Park – a 400-year-old landmark estate representing the most inspiring and immersive physical expression of the brand to date.
  • First constructed in 1615, the pedigreed property in the Cotswolds remained in the ownership of the Cartwright family until the mid-20th century.
  • Primarily Classical Revival in style with vestiges of Continental Baroque, Aynho has been meticulously restored and reimagined with great respect for its original vision.
  • RH England is located at Aynho Park, Aynho, Banbury and offers valet parking.

Springtime blooms have arrived at Biltmore

Retrieved on: 
Wednesday, March 15, 2023

Set against the backdrop of Biltmore House's European-inspired architecture, the estate's world-class landscapes thrive with a progression of color throughout the Biltmore Blooms season, April 1 – May 25.

Key Points: 
  • Set against the backdrop of Biltmore House's European-inspired architecture, the estate's world-class landscapes thrive with a progression of color throughout the Biltmore Blooms season, April 1 – May 25.
  • Musicians will be stationed on the first floor of Biltmore House, setting a sweet tone as guests tour through the house.
  • "He (Vanderbilt) enjoyed bringing beautiful objects to fill Biltmore House and sharing excellent vintages at his table," said Bill Cecil, President and CEO of Biltmore and great-grandson of George Vanderbilt.
  • Additional accommodations on the estate include Village Hotel on Biltmore Estate, and the Cottages on Biltmore Estate.

Eton Pharmaceuticals Reports Third Quarter Financial Results

Retrieved on: 
Monday, November 15, 2021

DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2021.

Key Points: 
  • DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today reported financial results for the third quarter ended September 30, 2021.
  • These events put us in an even stronger position to deliver significant revenue and reach sustained profitability in 2022, said Sean Brynjelsen, CEO of Eton Pharmaceuticals.
  • The product will be marketed by Azurity Pharmaceuticals and is expected to be available before the end of the year.
  • Eton now has six FDA-approved products, three of which (carglumic acid, EPRONTIA, and Rezipres) are expected to launch in the fourth quarter of 2021.

Eton Pharmaceuticals Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE®

Retrieved on: 
Monday, November 15, 2021

DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that it has entered into a multi-year agreement with Tolmar Pharmaceuticals, Inc. to co-promote ALKINDI SPRINKLE.

Key Points: 
  • DEER PARK, Ill., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) today announced that it has entered into a multi-year agreement with Tolmar Pharmaceuticals, Inc. to co-promote ALKINDI SPRINKLE.
  • We believe this will translate to significantly faster adoption of ALKINDI SPRINKLE and accelerate the time to reach peak conversion, said Sean Brynjelsen, CEO of Eton Pharmaceuticals.
  • Under terms of the agreement, Tolmars sales force will promote ALKINDI SPRINKLE to their pediatric endocrinology targets alongside FENSOLVI.
  • "Tolmar" refers to Tolmar Holding, Inc. and its wholly owned operating subsidiaries, Tolmar Inc., Tolmar Therapeutics, Inc., and Tolmar Pharmaceuticals, Inc. Tolmar global headquarters, product development and manufacturing facilities are based in northern Colorado, while Tolmar Pharmaceuticals' U.S. commercial business is based in Buffalo Grove, Illinois.

Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA™ (topiramate) Oral Solution

Retrieved on: 
Monday, November 8, 2021

DEER PARK, Ill. and WOBURN, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) and Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.

Key Points: 
  • DEER PARK, Ill. and WOBURN, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON) and Azurity Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.
  • This is a transformative day for patients living with epileptic seizures and migraines and their families and caregivers, said Amit Patel, Chairman and CEO of Azurity Pharmaceuticals.
  • EPRONTIA is the first oral liquid formulation of topiramate to be approved by the FDA.
  • We look forward to continuing to work with Azurity to achieve additional approvals from our CNS portfolio partnership, added Sean Brynjelsen, CEO of Eton Pharmaceuticals.

Christmas at Biltmore and Van Gogh Alive open Nov. 5

Retrieved on: 
Friday, November 5, 2021

Two experiences are available to enjoy Biltmore during the holiday season -- Christmas at Biltmore and Candlelight Christmas Evenings. The entire estate is open to guests as part of admission to either Christmas experience.

Key Points: 
  • Unique this year is the opportunity to also experience Van Gogh Alive presented by Grande Experiences, the first of three multi-sensory digital art exhibitions in a year-long series.
  • Dcor in Biltmore House includes 62 hand-decorated Christmas trees, over 14,000 ornaments, 45,000 holiday lights, 250 candles, 1,000 feet of garland, and 175 poinsettias.
  • Two experiences are available to enjoy Biltmore during the holiday season -- Christmas at Biltmore and Candlelight Christmas Evenings.
  • Don't miss the seasonal favorite Christmas at Biltmore Red and White wines in Biltmore Winery.

Eton Pharmaceuticals to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

Retrieved on: 
Wednesday, November 3, 2021

DEER PARK, Ill., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2021 financial and operating results on Monday, November 15, 2021.

Key Points: 
  • DEER PARK, Ill., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report third quarter 2021 financial and operating results on Monday, November 15, 2021.
  • Management will host a conference call and live audio webcast to discuss these results and provide a business update at 4:30 p.m.
  • In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors.
  • Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

Eton Pharmaceuticals Announces Acquisition of Approved Orphan Drug Product Carglumic Acid

Retrieved on: 
Thursday, October 28, 2021

The products Abbreviated New Drug Application, which is owned by Novitium Pharma, was approved by the U.S. Food and Drug Administration on October 13, 2021.

Key Points: 
  • The products Abbreviated New Drug Application, which is owned by Novitium Pharma, was approved by the U.S. Food and Drug Administration on October 13, 2021.
  • We are pleased to be offering patients a lower cost alternative to one of the most expensive treatments in the world, said Sean Brynjelsen, CEO of Eton Pharmaceuticals.
  • With our existing orphan drug commercial footprint and robust patient support services, we believe we are well positioned tocommercialize this product.
  • Eton Pharmaceuticals, Inc. is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

Service King Prepares to Bring Efficient Vehicle Collision Repair Experience to Deer Park, Illinois

Retrieved on: 
Thursday, September 30, 2021

"With 45 years of experience leading the automotive repair industry, Service King is proud to extend its services to Deer Park and its surrounding communities," said Service King Director of Construction and Development John Gageby.

Key Points: 
  • "With 45 years of experience leading the automotive repair industry, Service King is proud to extend its services to Deer Park and its surrounding communities," said Service King Director of Construction and Development John Gageby.
  • Service King Collision, which is now celebrating 45 years of experience in the automotive repair industry, is a leading national operator of comprehensive, high-quality auto body collision repair facilities.
  • Service King traces its roots back to Dallas, Texas and founder Eddie Lennox who opened the very first Service King in 1976.
  • Today, Service King operates locations in 24 states and the District of Columbia across the U.S.
    For more information and to find a local Service King, visit serviceking.com and follow Service King on Facebook , Instagram and Twitter .